Toshiki Takemoto

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

T. Koga, Kenichi Suda, Toshio Fujino et al. · Journal of Thoracic Oncology · 2021 · 251 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro

Toshio Fujino, Yoshihisa Kobayashi, Kenichi Suda et al. · Journal of Thoracic Oncology · 2019 · 175 citations · Full text

Medicine, Oncology, Pharmacology +14

Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)

Masaki Shimoji, Shigeki Shimizu, Katsuaki Sato et al. · Lung Cancer · 2016 · 167 citations

Medicine, Cancer Biology, Oncology +16

Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer

Yoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai et al. · Molecular Cancer Therapeutics · 2016 · 77 citations

Medicine, Oncology, Pharmacology +17

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study

T. Koga, Yoshihisa Kobayashi, Kenji Tomizawa et al. · Lung Cancer · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacology +16